AQS³®pro offers breakthrough in bioanalytical technology at WCBP 2019
The WCBP Symposium series was created to address issues at the interface of analytical development and global regulatory for biotechnology-derived health intervention products. The goal was to provide a forum for discussing the latest bioanalytical methods and their practical application to biotechnology pharmaceuticals and other health related products.
Our AQS³pro was a cutting edge addition to the new and existing technologies being showcased. This included both method and instrumental advances that are used for product characterization, process development, in-process analysis and validate release and stability testing.
Interested in learning more about how the AQS³pro fits into the technology landscape? Contact our team at email@example.com.